Annual cashflow statement for ZoomMed, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.

C2013
May 31st
C2014
May 31st
C2015
May 31st
2016
May 31st
2017
May 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.42-4.633.76-0.95-2.12
Depreciation
Non-Cash Items1.881.88-6.05-0.7170.231
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4.551.02-1.06-0.141.17
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-0.711-1.08-3.23-1.79-0.671
Capital Expenditures-0.415-0.258-0.035-0.276-0
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0270.5395.891.650
Sale of Fixed Assets
Sale/Maturity of Investment
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-0.3880.2815.861.37-0
Net Issuance / Retirement of Debt
Cash from Financing Activities00.59-2.210.1660.469
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.1-0.2060.414-0.251-0.202

Or unlock with your email

Or unlock with your email